Liposome Drug Delivery Market (Product, Technology) to See 8.8% CAGR Led by Liposomal Doxorubicin – The Insight Partners
Drugs and devices required for the drug delivery are required to undergo a thorough clinical development process in order to obtain FDA approval. The drug
Source: einnews.com